ID   QGY/cDDP
AC   CVCL_M360
SY   QGY/CDDP
DR   Wikidata; Q54948828
RX   PubMed=12478896;
RX   PubMed=19139770;
CC   Problematic cell line: Contaminated. Parent cell line (QGY-7703) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Doubling time: 45.7 +- 1.7 hours (PubMed=19139770).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6715 ! QGY-7703
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
RX   PubMed=12478896;
RA   Yang J.-X., Tang W.-X.;
RT   "Establishment of a cisplatin-induced human hepatocellular carcinoma
RT   drug-resistant cell line and its biological characteristics.";
RL   Ai Zheng 21:872-876(2002).
//
RX   PubMed=19139770;
RA   Yang J.-X., Luo Y., Qiu H.-M., Tang W.-X.;
RT   "Characterization and resistance mechanisms of cisplatin-resistant
RT   human hepatocellular carcinoma cell line.";
RL   Saudi Med. J. 30:35-40(2009).
//